Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Orchid CBD’s mix tilted decisively toward Pre-Roll at 50.0% share with year-over-year growth of 196.9% and month-over-month growth of 9.7%, while Vapor Pens held 26.5% share with 18.4% YoY growth but a 4.5% MoM decline. Flower accounted for 23.4% share with 57.0% YoY growth and a 2.7% MoM dip, alongside an average price decrease of 11.5% YoY across the brand and a current average of $25.98. With Pre-Roll also ranking 64 in British Columbia, the pattern implies Orchid CBD is consolidating around value-leaning inhalable formats where rapid Pre-Roll expansion and modest Vapor Pen contraction are reallocating share toward faster-turning SKUs.
The shift toward Pre-Roll (up 196.9% YoY and up 9.7% MoM) alongside declines in Vapor Pens (down 4.5% MoM despite 18.4% YoY growth) and Flower (down 2.7% MoM despite 57.0% YoY growth) suggests Orchid CBD is trading into channels where price elasticity favors lower-ticket, frequent-purchase items. Coupled with an 11.5% YoY reduction in average price and Pre-Roll’s 50.0% share, the brand’s positioning is trending toward an accessibly priced inhalables hub, where scale and velocity in Pre-Roll can buffer short-term softness in Vapor Pens and Flower while reinforcing visibility in Ontario and adjacent markets.
Competitive Landscape
Orchid CBD sits at rank #71 in ON Pre-Roll in October 2026, improving 24 places year over year from #95 and edging up 5 spots from #76 three months prior, while its best position of #69 in September 2026 was only two ranks higher than today; in contrast, Back Forty / Back 40 Cannabis climbed from #2 to #1 as its sales grew 75.6% year over year, and General Admission slipped from #1 to #2 with a 28.3% sales decline, indicating that Orchid CBD’s incremental rank gains amid top-tier reshuffling point to share stabilization rather than a breakout trajectory.
Notable Products
Orchid CBD’s sales in October 2026 are heavily concentrated in two formats: Pre-Roll and Vapor Pens together account for 76.5% of brand revenue, led by CBD Runtz Live Resin Cartridge (1g) at 26.5%. With 29.1% of sales coming from four products first sold in the last six months, most of its sales ride on a few formats and recent launches.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






